• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Multi-State Survival Model for Time to Breast Cancer Mortality among a Cohort of Initially Disease-Free Women.多状态生存模型在最初无病女性队列中用于乳腺癌死亡率的时间。
Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1582-1592. doi: 10.1158/1055-9965.EPI-21-1471.
2
Adult weight change and risk of postmenopausal breast cancer.成年人体重变化与绝经后乳腺癌风险
JAMA. 2006 Jul 12;296(2):193-201. doi: 10.1001/jama.296.2.193.
3
Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.加利福尼亚教师研究队列中绝经后妇女与妊娠相关因素及乳腺癌原位和浸润性乳腺癌的风险
Breast Cancer Res. 2010;12(3):R35. doi: 10.1186/bcr2589. Epub 2010 Jun 18.
4
Pre- to postdiagnosis leisure-time physical activity and prognosis in postmenopausal breast cancer survivors.绝经后乳腺癌幸存者诊断前后的休闲时间体力活动与预后。
Breast Cancer Res. 2019 Nov 7;21(1):117. doi: 10.1186/s13058-019-1206-0.
5
Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.超重、肥胖与绝经后浸润性乳腺癌风险:妇女健康倡议随机临床试验的二次分析。
JAMA Oncol. 2015 Aug;1(5):611-21. doi: 10.1001/jamaoncol.2015.1546.
6
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.雌激素加孕激素与绝经后妇女的乳腺癌发病率和死亡率。
JAMA. 2010 Oct 20;304(15):1684-92. doi: 10.1001/jama.2010.1500.
7
Relative weight at age 12 and risk of postmenopausal breast cancer.12岁时的相对体重与绝经后乳腺癌风险
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):374-8. doi: 10.1158/1055-9965.EPI-07-0389. Epub 2008 Feb 4.
8
Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States.美国夏威夷女性居民多民族队列中乳腺癌发病率和生存率的人体测量学预测指标
Cancer Causes Control. 1998 Mar;9(2):217-24. doi: 10.1023/a:1008842613331.
9
Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.雌激素加孕激素与妇女健康倡议观察研究中的乳腺癌发病率和死亡率。
J Natl Cancer Inst. 2013 Apr 17;105(8):526-35. doi: 10.1093/jnci/djt043. Epub 2013 Mar 29.
10
Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women.绝经前后女性中按激素受体分类的短期体重增加与乳腺癌风险
Breast Cancer Res Treat. 2015 Apr;150(3):643-53. doi: 10.1007/s10549-015-3344-0. Epub 2015 Mar 22.

引用本文的文献

1
Menopausal hormone therapy and incidence, mortality, and survival of breast cancer subtypes: a prospective cohort study.绝经后激素治疗与乳腺癌亚型的发病、死亡和生存:一项前瞻性队列研究。
Breast Cancer Res. 2024 Nov 4;26(1):151. doi: 10.1186/s13058-024-01897-4.
2
Identifying modifiable risk factors to prevent aggressive colorectal cancer.识别可改变的风险因素以预防侵袭性结直肠癌。
Int J Cancer. 2024 Oct 1;155(7):1191-1202. doi: 10.1002/ijc.34993. Epub 2024 May 8.

本文引用的文献

1
Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation.简化乳腺风险工具整合问卷风险因素、乳腺密度和多基因风险评分:开发与验证。
Cancer Epidemiol Biomarkers Prev. 2021 Apr;30(4):600-607. doi: 10.1158/1055-9965.EPI-20-0900. Epub 2020 Dec 4.
2
Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium.卵巢癌侵袭性与风险因素的关系:卵巢癌队列研究联盟的分析。
Int J Cancer. 2019 Jul 1;145(1):58-69. doi: 10.1002/ijc.32075. Epub 2019 Jan 14.
3
Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors.癌症与脂肪:脂肪组织与肿瘤之间的相互作用
Trends Cancer. 2018 May;4(5):374-384. doi: 10.1016/j.trecan.2018.03.004. Epub 2018 Apr 5.
4
Family history and risk of breast cancer: an analysis accounting for family structure.家族病史与乳腺癌风险:一项考虑家族结构的分析
Breast Cancer Res Treat. 2017 Aug;165(1):193-200. doi: 10.1007/s10549-017-4325-2. Epub 2017 Jun 3.
5
Weight and weight changes in early adulthood and later breast cancer risk.成年早期的体重及体重变化与后期患乳腺癌风险
Int J Cancer. 2017 May 1;140(9):2003-2014. doi: 10.1002/ijc.30627.
6
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.美国癌症协会/美国临床肿瘤学会乳腺癌生存者护理指南。
CA Cancer J Clin. 2016 Jan-Feb;66(1):43-73. doi: 10.3322/caac.21319. Epub 2015 Dec 7.
7
Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis.乳腺癌诊断后的体重增加与全因死亡率:系统评价与荟萃分析
J Natl Cancer Inst. 2015 Sep 30;107(12):djv275. doi: 10.1093/jnci/djv275. Print 2015 Dec.
8
Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients.激素疗法及其对乳腺癌患者预后的影响。
Geburtshilfe Frauenheilkd. 2015 Jun;75(6):588-596. doi: 10.1055/s-0035-1546149.
9
Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women.绝经前后女性中按激素受体分类的短期体重增加与乳腺癌风险
Breast Cancer Res Treat. 2015 Apr;150(3):643-53. doi: 10.1007/s10549-015-3344-0. Epub 2015 Mar 22.
10
Smoking and mortality--beyond established causes.吸烟与死亡——超越已知病因。
N Engl J Med. 2015 Feb 12;372(7):631-40. doi: 10.1056/NEJMsa1407211.

多状态生存模型在最初无病女性队列中用于乳腺癌死亡率的时间。

A Multi-State Survival Model for Time to Breast Cancer Mortality among a Cohort of Initially Disease-Free Women.

机构信息

Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

出版信息

Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1582-1592. doi: 10.1158/1055-9965.EPI-21-1471.

DOI:10.1158/1055-9965.EPI-21-1471
PMID:35654356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9348829/
Abstract

BACKGROUND

Identifying risk factors for aggressive forms of breast cancer is important. Tumor factors (e.g., stage) are important predictors of prognosis, but may be intermediates between prediagnosis risk factors and mortality. Typically, separate models are fit for incidence and mortality postdiagnosis. These models have not been previously integrated to identify risk factors for lethal breast cancer in cancer-free women.

METHODS

We combined models for breast cancer incidence and breast cancer-specific mortality among cases into a multi-state survival model for lethal breast cancer. We derived the model from cancer-free postmenopausal Nurses' Health Study women in 1990 using baseline risk factors. A total of 4,391 invasive breast cancer cases were diagnosed from 1990 to 2014 of which 549 died because of breast cancer over the same period.

RESULTS

Some established risk factors (e.g., family history, estrogen plus progestin therapy) were not associated with lethal breast cancer. Controlling for age, the strongest risk factors for lethal breast cancer were weight gain since age 18: > 30 kg versus ± 5 kg, RR = 1.94 [95% confidence interval (CI) = 1.38-2.74], nulliparity versus age at first birth (AAFB) < 25, RR = 1.60 (95% CI = 1.16-2.22), and current smoking ≥ 15 cigarettes/day versus never, RR = 1.42 (95% CI = 1.07-1.89).

CONCLUSIONS

Some breast cancer incidence risk factors are not associated with lethal breast cancer; other risk factors for lethal breast cancer are not associated with disease incidence.

IMPACT

This multi-state survival model may be useful for identifying prediagnosis factors that lead to more aggressive and ultimately lethal breast cancer.

摘要

背景

识别乳腺癌侵袭性形式的风险因素很重要。肿瘤因素(例如分期)是预后的重要预测因素,但可能是诊断前风险因素与死亡率之间的中介。通常,为诊断后发病率和死亡率分别拟合模型。这些模型以前没有整合过,以确定无癌女性致命性乳腺癌的风险因素。

方法

我们将病例的乳腺癌发病率和乳腺癌特异性死亡率模型合并到一个致命性乳腺癌的多状态生存模型中。我们使用 1990 年基线风险因素从无癌症的绝经后护士健康研究女性中得出该模型。1990 年至 2014 年期间诊断出 4391 例浸润性乳腺癌病例,同期有 549 例死于乳腺癌。

结果

一些已确立的风险因素(例如家族史、雌激素加孕激素治疗)与致命性乳腺癌无关。控制年龄后,致命性乳腺癌最强的风险因素是 18 岁以后的体重增加:> 30 公斤与± 5 公斤相比,RR = 1.94 [95%置信区间(CI)= 1.38-2.74],初产年龄(AAFB)< 25 岁的未婚与初产年龄(AAFB)< 25 岁的未婚相比,RR = 1.60 [95%置信区间(CI)= 1.16-2.22],当前吸烟≥15 支/天与从不吸烟相比,RR = 1.42 [95%置信区间(CI)= 1.07-1.89]。

结论

一些乳腺癌发病率风险因素与致命性乳腺癌无关;其他致命性乳腺癌的风险因素与疾病发病率无关。

影响

这种多状态生存模型可能有助于识别导致更具侵袭性并最终致命性乳腺癌的诊断前因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/9348829/9d52619c5f05/nihms-1814669-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/9348829/9d52619c5f05/nihms-1814669-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/9348829/9d52619c5f05/nihms-1814669-f0001.jpg